Surrogate end points, health outcomes, and the drug-approval process for the treatment of risk factors for cardiovascular disease

Bruce M. Psaty; Noel S. Weiss; Curt D. Furberg; Thomas D. Koepsell; David S. Siscovick; Frits R. Rosendaal; Nicholas L. Smith; Susan R. Heckbert; Robert C. Kaplan; Danyu Lin; Thomas R. Fleming; Edward H. Wagner

doi:10.1001/jama.282.8.786

Surrogate end points, health outcomes, and the drug-approval process for the treatment of risk factors for cardiovascular disease

Bruce M. Psaty, Noel S. Weiss, Curt D. Furberg, Thomas D. Koepsell, David S. Siscovick, Frits R. Rosendaal, Nicholas L. Smith, Susan R. Heckbert, Robert C. Kaplan, Danyu Lin, Thomas R. Fleming, Edward H. Wagner

Research output: Contribution to journal › Comment/debate › peer-review

169 Scopus citations

Original language	English (US)
Pages (from-to)	786-790
Number of pages	5
Journal	JAMA - Journal of the American Medical Association
Volume	282
Issue number	8
DOIs	https://doi.org/10.1001/jama.282.8.786
State	Published - Aug 25 1999
Externally published	Yes

ASJC Scopus subject areas

General Medicine

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1001/jama.282.8.786

Cite this

Psaty, B. M., Weiss, N. S., Furberg, C. D., Koepsell, T. D., Siscovick, D. S., Rosendaal, F. R., Smith, N. L., Heckbert, S. R., Kaplan, R. C., Lin, D., Fleming, T. R., & Wagner, E. H. (1999). Surrogate end points, health outcomes, and the drug-approval process for the treatment of risk factors for cardiovascular disease. JAMA - Journal of the American Medical Association, 282(8), 786-790. https://doi.org/10.1001/jama.282.8.786

Psaty, BM, Weiss, NS, Furberg, CD, Koepsell, TD, Siscovick, DS, Rosendaal, FR, Smith, NL, Heckbert, SR, Kaplan, RC, Lin, D, Fleming, TR & Wagner, EH 1999, 'Surrogate end points, health outcomes, and the drug-approval process for the treatment of risk factors for cardiovascular disease', JAMA - Journal of the American Medical Association, vol. 282, no. 8, pp. 786-790. https://doi.org/10.1001/jama.282.8.786

@article{7a44e9d992db49c0b0300fd7b4f9e663,

title = "Surrogate end points, health outcomes, and the drug-approval process for the treatment of risk factors for cardiovascular disease",

author = "Psaty, {Bruce M.} and Weiss, {Noel S.} and Furberg, {Curt D.} and Koepsell, {Thomas D.} and Siscovick, {David S.} and Rosendaal, {Frits R.} and Smith, {Nicholas L.} and Heckbert, {Susan R.} and Kaplan, {Robert C.} and Danyu Lin and Fleming, {Thomas R.} and Wagner, {Edward H.}",

year = "1999",

month = aug,

day = "25",

doi = "10.1001/jama.282.8.786",

language = "English (US)",

volume = "282",

pages = "786--790",

journal = "JAMA - Journal of the American Medical Association",

issn = "0098-7484",

publisher = "American Medical Association",

number = "8",

}

TY - JOUR

T1 - Surrogate end points, health outcomes, and the drug-approval process for the treatment of risk factors for cardiovascular disease

AU - Psaty, Bruce M.

AU - Weiss, Noel S.

AU - Furberg, Curt D.

AU - Koepsell, Thomas D.

AU - Siscovick, David S.

AU - Rosendaal, Frits R.

AU - Smith, Nicholas L.

AU - Heckbert, Susan R.

AU - Kaplan, Robert C.

AU - Lin, Danyu

AU - Fleming, Thomas R.

AU - Wagner, Edward H.

PY - 1999/8/25

Y1 - 1999/8/25

UR - http://www.scopus.com/inward/record.url?scp=0033603785&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033603785&partnerID=8YFLogxK

U2 - 10.1001/jama.282.8.786

DO - 10.1001/jama.282.8.786

M3 - Comment/debate

C2 - 10463718

AN - SCOPUS:0033603785

SN - 0098-7484

VL - 282

SP - 786

EP - 790

JO - JAMA - Journal of the American Medical Association

JF - JAMA - Journal of the American Medical Association

IS - 8

ER -

Surrogate end points, health outcomes, and the drug-approval process for the treatment of risk factors for cardiovascular disease

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Cite this